Agile Therapeutics Inc - ESG Rating & Company Profile powered by AI
The page contains a free Environmental, Social and Governance report for Agile Therapeutics Inc. If you work at Agile Therapeutics Inc and you wish to use your Sustainability rating, please contact us. This page contains a Q&A table for Agile Therapeutics Inc.
Agile Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1234 | Quanterix Corp | 3.4 | Medium |
1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
1253 | Agile Therapeutics Inc | 3.3 | Medium |
1253 | Calithera Biosciences Inc | 3.3 | Medium |
1253 | Cara Therapeutics Inc | 3.3 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Agile Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Agile Therapeutics Inc disclose current and historical energy intensity?
Does Agile Therapeutics Inc report the average age of the workforce?
Does Agile Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does Agile Therapeutics Inc disclose its ethnicity pay gap?
Does Agile Therapeutics Inc disclose cybersecurity risks?
Does Agile Therapeutics Inc offer flexible work?
Does Agile Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Agile Therapeutics Inc disclose the number of employees in R&D functions?
Does Agile Therapeutics Inc conduct supply chain audits?
Does Agile Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Agile Therapeutics Inc conduct 360 degree staff reviews?
Does Agile Therapeutics Inc disclose the individual responsible for D&I?
Does Agile Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Agile Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does Agile Therapeutics Inc disclose water use targets?
Does Agile Therapeutics Inc have careers partnerships with academic institutions?
Did Agile Therapeutics Inc have a product recall in the last two years?
Does Agile Therapeutics Inc disclose incidents of discrimination?
Does Agile Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Agile Therapeutics Inc issued a profit warning in the past 24 months?
Does Agile Therapeutics Inc disclose parental leave metrics?
Does Agile Therapeutics Inc disclose climate scenario or pathway analysis?
Does Agile Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Agile Therapeutics Inc disclose the pay ratio of women to men?
Does Agile Therapeutics Inc support suppliers with sustainability related research and development?
Does Agile Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Agile Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Agile Therapeutics Inc involved in embryonic stem cell research?
Does Agile Therapeutics Inc disclose GHG and Air Emissions intensity?
Does Agile Therapeutics Inc disclose its waste policy?
Does Agile Therapeutics Inc report according to TCFD requirements?
Does Agile Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Agile Therapeutics Inc disclose energy use targets?
Does Agile Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Agile Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Agile Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.